Expression and DNA methylation status of microRNA-375 in patients with type 2 diabetes mellitus

Molecular Medicine Reports

Volumn 9, Issue 3, 2014, Pages 967-972

  Sun, Kan ^a   Chang, Xiangyun ^a   Yin, Liang ^a   Li, Jun ^a   Zhou, Ting ^a   Zhang, Chen ^a   Chen, Xuan ^a  

^a SHIHEZI UNIVERSITY   (China)

Author keywords

Methylation; MiR 375; Type 2 diabetes

Indexed keywords

ADULT; CPG ISLANDS; DIABETES MELLITUS, TYPE 2; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROMOTER REGIONS, GENETIC; PROSPECTIVE STUDIES; UP-REGULATION;

EID: 84893826992     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1872     Document Type: Article

References (23)

1. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA and Butler PC: Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52: 102-110, 2003.
2. Guillausseau PJ, Meas T, Virally M, Laloi-Michelin M, Médeau V and Kevorkian JP: Abnormalities in insulin secretion in type 2 diabetes mellitus. Diabetes Metab 34 (Suppl 2): S43-S48, 2008.
3. Ambros V: The functions of animal microRNAs. Nature 431: 350-355, 2004.
4. Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233, 2009.
5. Uhlmann S, Zhang JD, Schwäger A, Mannsperger H, Riazalhosseini Y, Burmester S, et al: miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer. Oncogene 29: 4297-4306, 2010.
6. Chang TC and Mendell JT: microRNAs in vertebrate physiology and human disease. Annu Rev Genomics Hum Genet 8: 215-239, 2007.
7. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, Macdonald PE, et al: A pancreatic islet-specifi c microRNA regulates insulin secretion. Nature 432: 226-230, 2004.
8. Poy MN, Hausser J, Trajkovski M, Braun M, Collins S, Rorsman P, et al: miR-375 maintains normal pancreatic alpha-and beta-cell mass. Proc Natl Acad Sci USA 106: 5813-5818, 2009.
9. Baroukh N, Ravier MA, Loder MK, Hill EV, Bounacer A, Scharfmann R, et al: MicroRNA-124a regulates Foxa2 expression and intracellular signaling in pancreatic beta-cell lines. J Biol Chem 282: 19575-19588, 2007.
10. Plaisance V, Abderrahmani A, Perret-Menoud V, Jacquemin P, Lemaigre F and Regazzi R: MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells. J Biol Chem 281: 26932-26942, 2006.
11. Zhao H, Guan J, Lee HM, Sui Y, He L, Siu JJ, et al: Up-regulated pancreatic tissue microRNA-375 associates with human type 2 diabetes through beta-cell deficit and islet amyloid deposition. Pancreas 39: 843-846, 2010.
12. Gardner RJ, Mackay DJ, Mungall AJ, Polychronakos C, Siebert R, Shield JP, et al: An imprinted locus associated with transient neonatal diabetes mellitus. Hum Mol Genet 9: 589-596, 2000.
13. Ling C, Del Guerra S, Lupi R, Rönn T, Granhall C, Luthman H, et al: Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetologia 51: 615-622, 2008.
14. de Souza Rocha Simonini P, Breiling A, Gupta N, Malekpour M, Youns M, Omranipour R, et al: Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells. Cancer Res 70: 9175-9184, 2010.
15. Tsukamoto Y, Nakada C, Noguchi T, Tanigawa M, Nguyen LT, Uchida T, et al: MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res 70: 2339-2349, 2010.
16. Kong KL, Kwong DL, Chan TH, Law SY, Chen L, Li Y, et al: MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor. Gut 61: 33-42, 2012.
17. Yang YN, Xie X, Ma YT, Li XM, Fu ZY, Ma X, et al: Type 2 diabetes in Xinjiang Uygur Autonomous Region, China. PLoS One 7: e35270, 2012.
18. Lin HJ, Zuo T, Lin CH, Kuo CT, Liyanarachchi S, Sun S, et al: Breast cancer-associated fibroblasts confer AKT1-mediated epigenetic silencing of cystatin M in epithelial cells. Cancer Res 68: 10257-10266, 2008.
19. Szczyrba J, Nolte E, Wach S, Kremmer E, Stöhr R, Hartmann A, et al: Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma. Mol Cancer Res 9: 791-800, 2011.
20. Ding L, Xu Y, Zhang W, Deng Y, Si M, Du Y, Yao H, et al: MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Res 20: 784-793, 2010.
21. Li Y, Xu X, Liang Y, Liu S, Xiao H, Li F, et al: miR-375 enhances palmitate-induced lipoapoptosis in insulin-secreting NIT-1 cells by repressing myotrophin (V1) protein expression. Int J Clin Exp Pathol 3: 254-264, 2010.
22. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105: 10513-10518, 2008.
23. Weber B, Stresemann C, Brueckner B and Lyko F: Methylation of human microRNA genes in normal and neoplastic cells. Cell Cycle 6: 1001-1005, 2007.